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Stent Recoil and Angiographic Outcome in Drug Eluting Stents. Results of the
STEREO-DES pilot study
Javier Escaned, Jorge Sandoval, Humberto Colmenarez, Eliazar Arellano, Nieves
Gonzalo, Pilar Jimenez-Quevedo, Fernando Alfonso, Antonio Fernández-Ortiz,
Borja Ibañez, Eulogio García, Camino Bañuelos, Rosana Hernandez, Carlos
Macaya
Cardiovascular Institute, Hospital Clinico San Carlos, Madrid, Spain
Background: Long-term efficacy of drug eluting stents (DES) can be influenced by
structural and drug-eluting cover characteristics, but the independent contribution of
these two aspects to long term DES performance remains unknown. Stent recoil (SR)
may reflect structural characteristics of DES, but its quantification in-vivo is difficult.
Methods: We prospectively investigated the role of SR in 4 different DES made of
stainless steel (A and B), cobalt chromium (C), and platinum chromium (D) in stable
patients. Eluted drugs were paclitaxel (A and B) and everolimus (C and D). SR was
measured using a novel methodology with digitally enhanced angiographic stent
imaging (DEASI). Absolute (mm) and relative (%) SR (%) was calculated from
measurements during and after deployment. 9-month angiographic follow-up was 70%.
Relevant QCA parameters, including late luminal loss (LLL), were measured.
Results: 97 DES (22 A, 25 B, 26 C and 24 D) were implanted. Larger stent diameters
in A and less calcification in C groups were noted. Overall absolute stent recoil was
0.27±0.13 mm, with significant differences between B (0.31±0.18 mm) and D
(0.23±0.14 mm, p=0.04). Overall relative SR was 8.66±4.10%.. Average LLL was
0.44±0.47 mm, with significant differences between DES, ranging from 0.25±0.20 (D)
to 0.94±0.78 (B) mm. Angiographic restenosis rates were 0% A (0/17), 23% B (3/13),
0% C (0/16) and 0% D (0/14). Univariate regression analysis showed a significant
relationship between SR and LLL (r=0.28, p=0.029). Multivariate regression analysis
with adjustment to stent nominal diameter, calcification, diabetes and DES type
identified SR (beta 1.20, p=0.007) and B type DES (beta 0.67, p<0.0001) as
independent predictors of LLL (r=0.65, p<0.0001).
Conclusion: 1) Marked variations in SR between different DES were documented in
vivo with a novel DEASI method. 2) Stent recoil was identified as an independent
significant predictor of LLL. 3) These observations stress the importance of SR and
suggest that both structural and anti-proliferative characteristics of DES influence long-
term angiographic outcome.
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Impact of Peristent Plaque Change after Drug-Eluting Stents Implantation -
Comparison between Zotarolimus-Eluting Stents and Paclitaxel-Eluting Stents-
Yoshitaka Muraoka, Shinjo Sonoda, Kuninobu Kashiyama, Reo Anai, Fumihiko
Kamezaki, Yuki Tsuda, Masaru Araki, Masahiro Okazaki, Yutaka Otsuji
Department of cardiovascular medicine, University of Occupational and
Environmental Health, Kitakyusyu, Japan
Background: Previous intravascular ultrasound (IVUS) study revealed that first-
generation drug-eluting stents caused positive remodeling which could be related to
very late stent thrombosis. We evaluated peristent plaque change after zotarolimus-
eluting stents (ZES) implantation in comparison with paclitaxel-eluting stents (PES)
implantation, using gray-scale IVUS and integrated backscatter IVUS (IB-IVUS).
Methods: We randomly assigned 44 consecutive patients with de-novo lesions to treat
with ZES (n=22) and PES (n=22). Serial volumetric IVUS analysis was performed
after stenting and at 8-month follow-up. Peristent plaque (plaque outside stent struts)
components were analyzed in the whole stent segment with the largest vessel area at
baseline using IB-IVUS. We compared serial change of peristent plaque components
in the same segments in both groups, and evaluated the relationship between systemic
inflammation scores (white blood cell fraction and high-sensitive C-reactive protein)
and peristent plaque change.
Results: In PES, vessel volume in the whole stent segment significantly increased (356
to 380mm3, p<0.001), whereas it did not change in ZES (314 to 314mm3, p=0.99).
Serial IB-IVUS analysis showed fibrous plaque increased in both groups (PES: 3.0 to
3.6mm2, p=0.059, ZES: 2.9 to 4.0mm2, p<0.0001). Lipid plaque significantly
increased in PES (4.0 to 4.8mm2, p=0.02), however, that of ZES significantly
decreased (5.0 to 3.5mm2, p<0.0001). Lipid plaque change at the largest vessel area
was not related to any systemic inflammation scores in ZES. However, lipid plaque
change was significantly related to eosinophil change in PES (r=0.51, p=0.02). There
was no late and very late stent thrombosis up to 24-month follow-up in both groups.
Conclusion: Chronic peristent plaque change after PES implantation was completely
different from that after ZES implantion. Long-term clinical follow-up will be required
to confirm the impact of these findings obtained from this study.
TCT-635
Distorted Balloon Shape During Predilatation Before Stenting Predicts Stent
Underexpansion
Shinichiro Yamada, Hiroyuki Shibata, Takatoshi Hayashi, Tomofumi Takaya, Naoki
Miyoshi, Shougo Oishi, Yasuyo Tainiguchi, Katsunori Okajima, Akira Shimane,
Kiminobu Yokoi, Gaku Kanda, Seiichi Kobayashi, Takayoshi Toba, Mitsuhiro
Yokoyamada
Himeji Cardiovascular Center, Himeji, Japan
Background: Suboptimal stent expansion has become recognized as an important risk
factor not only for drug-eluting stent (DES) failure (restenosis) but also for the more
serious and rare event of stent thrombosis. The cause of stent underexpansion seems
to be on the hardness of lesion, however, it is hard to know the information of such
lesion hardness from angiography. In this study, we focused on the shape of balloon
during pre-stent dilatation as a predictor of lesion hardness and as a result, stent
underexpansion.
Methods: We analyzed 147 stented lesions (104 patients) in which intravascular
ultrasound (IVUS) revealed calcified plaques. IVUS was performed before ballooning
and after DES (Taxus/Endeavor/XienceV) implantation. Predilatation balloon was
inflated until indentation disappeared, and then stent was implanted using standard
technique. We divided them into two groups according to balloon shape during
predilatation. Straighten shape (balloon shape angle < 5 degree on angiography; group
A, N=103) or distorted shape (looking curved or sigmoid; groupB, N=41) on
fluoroscopy. Minimal stent cross sectional area (CSA) and symmetry index were
analyzed from post-stent IVUS data. We also calculated the ‘estimated’ stent-CSA by
using compliance chart of each DES. Ratio of minimal/estimated stent-CSA (Min/E
ratio) was then calculated. M/E ratio and symmetry index were compared between two
groups.
Results: Baseline and lesion characteristics were similar between two groups.
However, M/E ratio in group B was significantly lower than in group A (0.56+-0.11
vs. 0.68+-0.10, p<0.001). Furthermore, symmetry index in group B was significantly
lower than in group A (0.77+-0.08 vs. 0.84+-0.06, p<0.001). These data suggested that
distorted shape of predilation balloon is strongly associated with stent underexpansion.
Conclusion: Distorted shape of balloon during predilatation can serve as a useful
predictor of DES underexpansion. To prevent the future serious events, higher pressure
stent implantation, and if required from IVUS result, post dilatation using high pressure
balloon is recommended when predilatation balloon looks distorted.
TCT-636
Frequency and Distribution of Thin-Capped Fibroatheroma in the Left Main
Coronary Artery: A Virtual Histology Intravascular Ultrasound Analysis
Sang-Wook Kim1, Gary S Mintz2, Wang Soo Lee1, Jee Eun Kwon1, Min Seok Oh1,
Kwang Je Lee1, Chee Jeong Kim1, Tae Ho Kim1, Neil J Weissman3
1Interventional Cardiology, Chung-Ang University Hospital, Seoul, Republic of
Korea; 2Cardiovascular Research Foundation, New York, NY; 3Washington Hospital
Center, Washington, DC
Background: We assessed the frequency and distribution of Virtual Histology
Intravascular Ultrasound (VH-IVUS) thin-capped fibroatheromas (VH-TCFA) in the
left main coronary artery (LM) in 423 pts.
Methods: VH-TCFA was defined as necrotic core (NC) >10% of plaque area within
a plaque burden of >40% and >30° NC abutting the lumen in at least 3 consecutive
frames. Positive remodeling was defined as a remodeling index (lesion/reference EEM
[external elastic membrane] area) >1.05.
Results: Overall, the frequency of VH-TCFA was only 10.4% (44/423); 30 in pts with
acute coronary syndrome and 14 in pts with stable angina. Pt age 63±12 yrs vs 61±11
yrs) and diabetes frequency (27% vs 27%) were similar in LM-TCFA vs LM without
TCFA. LM length and EEM area was similar in LM with vs without VH-TCFA;
however, minimal lumen area was smaller in LM-TCFA (p<0.0001, Table). Although
LM-TCFA had a higher plaque burden (p<0.0001), larger necrotic core area
(p<0.0001), and more dense calcium (p=0.0002) at the maximum NC site compared
to LM without TCFA, positive remodeling was present in only 18% (8/44) of LM-
TCFA. Overall, 59% of LM-TCFA were located in mid-body and the rest at the distal
bifurcation. Minimal lumen area was smaller in mid-body LM-TCFA vs distal LM-
TCFA (9.12±3.62 mm2 vs 11.89±3.34 mm2, p=0.017). Plaque composition including
necrotic core area was similar.
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Conclusion: LM-VH-TCFA are clustered in mid-body of the left main artery with
infrequent positive remodeling.
TCT-637
In Vivo Characterization of Bioresorbable Vascular Scaffold Strut Interfaces
Using Optical Coherence Tomography with Gaussian Line Spread Function
Analysis
Alexander Sheehy1, Juan Luis Gutiérrez-Chico2, Roberto Diletti2, James P
Oberhauser1, Thierry Glauser1, Joel Harrington1, Mary Beth Kossuth1, Richard J
Rapoza1, Yoshinobu Onuma2, Patrick W. Serruys2
1Abbott Vascular, Santa Clara, CA; 2Interventional Cardiology, Erasmus MC,
Rotterdam, Netherlands
Background: Optical coherence tomography (OCT) of a bioresorbable vascular
scaffold (BVS) produces a highly reflective signal outlining struts. This signal
interferes with the measurement of strut thickness, as the boundaries cannot be
accurately identified, and with the assessment of coverage, because the neointimal
backscattering convolutes that of the polymer, frequently making them
indistinguishable from one another. We hypothesize that Gaussian line spread functions
(LSFs) can facilitate identification of strut boundaries, improving the accuracy of strut
thickness measurements and coverage assessment.
Methods: 48 randomly selected BVS struts from 12 patients in the ABSORB Cohort
B clinical study and 4 Yucatan minipigs were analyzed at baseline and follow-up (6
months in humans, 28 days in pigs). Signal intensities from the raw OCT backscattering
were fit to Gaussian LSFs for each interface, from which peak intensity and full-width-
at-half-maximum (FWHM) were calculated.
Results: Neointimal coverage resulted in significantly different LSFs and higher
FWHM values relative to uncovered struts at baseline (p<0.0001). Abluminal polymer-
tissue interfaces were also significantly different between baseline and follow-up
(p=0.0004 in humans, p<0.0001 in pigs). Using the location of the half-max of the LSF
as the polymer-tissue boundary, the average strut thickness was 158 ± 11 μm at baseline
and 152 ± 20 μm at 6 months (p=0.886), not significantly different from nominal strut
thickness.
Conclusion: Fitting the raw OCT backscattering signal to a Gaussian LSF facilitates
identification of the interfaces between BVS polymer and lumen or tissue. Such
analysis enables more precise measurement of the strut thickness and an objective
assessment of coverage.
TCT-638
Changes In Quantitative IVUS-derived Hyper-echogenicity Of Everolimus-
eluting Bioresorbable Vascular Scaffold In Relationship To Coronary Arterial
Remodeling And Baseline Morphology Of The Scaffolded Plaque. Insight From
ABSORB Trial
Salvatore Brugaletta1, 2, Patrick W Serruys1, Hector M. Garcia-Garcia1, 3, Josep
Gomez-Lara1, Vasim Farooq1, Robert Jan van Geuns1, Leif Thuesen4, Dariuz
Dudek5, Jacques Koolen6, Bernard Chevalier7, Dougal McClean8, Stephan
Windecker9, Pieter C. Smits10, Bernard de Bruyne11, Robert Whitbourn12, Ian
Meredith13, Ron T. van Domburg1, Kenij Sihan1, Sebastiaan de Winter1, Susan
Veldhof14, Richard Rapoza15, John A. Ormiston16, Nico Bruining1
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Clinic, Barcelona, Spain; 3Cardialysis, Rotterdam, Netherlands; 4Skejby Sygehus,
Aarhus University Hospital, Aarhus, Denmark; 5Jagiellonian University, Krakow,
Poland; 6Catharina Hospital, Eindhoven, Netherlands; 7Institut Cardiovasculaire
Paris Sud, Massy, France; 8Christchurch Hospital, Christchurch, New Zealand;
9Bern University Hospital, Bern, Switzerland; 10Maasstad Hospital, Rotterdam,
Netherlands; 11Cardiovascular Center Aalstl, Aalst, Belgium; 12St Vincent’s Hospital,
Fitzroy, Australia; 13Monash Cardiovascular Research Centre,, Monash, Australia;
14Abbott Vascular, Diegem, Belgium; 15Abbott Vascular, Santa Clara, CA;
16Auckland City Hospital, Auckland, New Zealand
Background: Intravascular ultrasound-derived echogenicity analyses have been used
to estimate the degradation of the ABSORB scaffold in the ABSORB trials. Coronary
arterial remodeling and baseline IVUS morphology of the scaffolded plaque may be
related to the subsequent degradation of the ABSORB scaffold. We sough to analyze
the changes in ultrasound characteristics of the ABSORB scaffold in relationship to
the baseline IVUS morphology and remodeling pattern of the plaque scaffolded.
Methods: The study population consisted of all patients with available echogenicity
analyses at baseline and 6 (n=28) or 12 (n=35) months follow-up. Coronary remodeling
was evaluated for the scaffolded segments by the serial assessment of changes in
atheroma and EEM areas and classified as positive (PR), incomplete (IR) or negative
(NR) remodeling. Baseline plaque morphology was visually assessed by IVUS in each
cross-sectional area as calcified, fibro-necrotic or fibro-cellular.
Results: At 6 months no changes in hyper-echogenicity were found between the
baseline IVUS plaque morphology and various patterns of remodeling. At 12 months,
plaques scaffolded with PR were associated with a larger reduction in hyper-
echogenicity (median [95%CI] -30.56%[-38.92 – -20.43]) compared with IR
(-19.40%[-25.57 – -5.01]) or NR (-1.18%[-17.25 – 7.03]; p=0.017). At 12 months, a
trend toward a greater reduction in hyper-echogenicity in calcified plaques compared
to the other types was evident (calcified plaques -20.48%[-30.32 – -10.65] vs. fibro-
necrotic plaques -14.54%[-23.12 – -5.97] vs. fibro-cellular plaques -8.61[-19.71 –
2.49], p=0.054).
Conclusion: At 12 months, baseline IVUS morphology and positive remodeling of
the plaque scaffolded appear to influence the reduction in ultrasound material
parameters of the ABSORB scaffold. The two years results will be available at the time
of the presentation.
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Plaque Morphology with Optical Coherence Tomography and Biomarkers
Kohei Koyama, Takashi Shimozato, Eiji Takahashi, Ken Kongoji, Fumihiko Miyake
St.marianna university, Kawasaki, Japan
Background: Advanced imaging modalities provide various findings in unstable
plaque in the coronary arteries. Optical coherence tomography (OCT) evaluates thin-
cap fibroatheroma (TCFA); whereas biomarkers reflect pathological process of
cardiovascular disease (CVD), such as unstable plaque, plaque rupture and thrombus
formation in acute coronary syndrome. The association between unstable plaque and
biomarkers has not been elucidated in vivo. Here, this study aimed to evaluate the
correlation between biomarkers (interleukin-6, IL-6; matrix metalloproteinase-9,
MMP-9, high sensitive C-reactive protein, hs-CRP) and plaque morphology using OCT
and to investigate the usefulness of these biomarkers for early risk stratification.
Methods: This study included 46 CVD patients (26 ACS patients and 20 patients with
effort angina pectoris; EAP) who underwent percutaneous coronary intervention (PCI).
Blood samples were collected before PCI. Culprit lesions were identified using
electrocardiography, coronary angiography, cardiac scintigraphy and pressure wire.
OCT was performed before stent implantation for assessing fibrous cap thickness,
TCFA (plaque burden >2 quadrant, fibrous cap measurement <80μm), and the presence
/ absence of thrombus and plaque rupture.
Results: Hs-CRP was significantly higher in ACS patients than EAP patients
(0.313±0.094 vs. 0.073±0.011mg/dl, p=0.16). The patients with TCFA had significantly
higher hs-CRP (0.332±0.108mg/dl vs. 0.086±0.019mg/dl, p=0.16) and IL-6
(14.16±7.43pg/ml vs. 3.72±1.39pg/dl, p=0.47) than those without TCFA. Fibrous cap
thickness was significantly thinner (80.8±12.2μm vs.177.5±18.8μm, p<0.001) and
plaque rapture and thrombus were significantly greater in ACS patients than EAP
patients. Fibrous cap thickness correlated with hs-CRP (r =-0.37, p=0.037) but not
correlated with IL-6 (r=-0.175, p=0.39) or MMP-9 (r=-0.117, p=0.354). The receiver
operator characteristic (ROC) curves resulted that the specificities and sensitivities of
hs-CRP and IL-6 were 70% and 72% (cut off at 0.081mg/dl) and 70% and 73% (cut
off at 1.81pg/ml), respectively, suggesting that these biomarkers probably identify
TCFA.
Conclusion: Hs-CRP and IL-6 were predictors of unstable plaque assessed with OCT.
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Totally occluded infarct-related arteries in STEMI patients are associated with
more calcification and myonecrosis
Sang-Wook Kim1, Gary S Mintz2, Wang Soo Lee1, Young Joon Hong3, Sung Yun Lee4,
Jee Eun Kwon1, Kwang Je Lee1, Tae Ho Kim1, Chee Jeong Kim1, Neil J Weissman5
1Interventional Cardiology, Chung-Ang University Hospital, Seoul, Republic of
Korea; 2Cardiovascular Research Foundation, New York, NY; 3Chonnam National
University Hospital, Gwangju, Republic of Korea; 4Inje University Ilsan Paik
Hospital, Ilsan, Republic of Korea; 5Washington Hospital Center, Washington, DC
Background: We assessed culprit lesions of infarct-related arteries (IRA) using Virtual
Histology Intravascular Ultrasound (VH-IVUS) in 112 pts with acute ST elevation
myocardial infarction (STEMI).
Methods: STEMI pts were divided into 2 groups: IRA with total occlusion (TOI, n=67)
and partial-occluded IRA(POI, n=45). TIMI thrombus grade was evaluated: Gr 0, no
angiographic thrombus; Gr 1, possible thrombus; Gr 2, definite thrombus with greatest
dimensions ≤1/2 the vessel diameter(VD); Gr 3, definite thrombus with greatest
dimension 1/2 to 2 VD; Gr 4, definite thrombus with the largest dimension ≥2 VD;
and Gr 5; total occlusion. VH-thin-capped fibroatheroma (VH-TCFAs) was defined as
necrotic core (NC) >10% of plaque area, plaque burden >40%, and NC in contact with
the lumen for ≥3 image slices. Positive remodeling was defined as lesion/reference
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